Jeffrey Kahn, PhD, MPH - the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the Levi Professor of Bioethics and Public Policy - provides an introduction to the ethics of gene editing. In this first session, Dr. Kahn uses the first case in the world of the creation of a so-called “savior sibling” to help illustrate the ethical and policy issues arising when new combinations of biotechnologies challenge existing limits.

The combination of reproductive and genetic testing technologies increasingly allow for parents to select traits in what they hope will be their future children. This session will use the first case in the world of the creation of a so-called “savior sibling” to help illustrate the ethical and policy issues arising when new combinations of biotechnologies challenge existing limits.